China's Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27b in Hong Kong IPO

China's Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27b in Hong Kong IPO

REUTERS/Bobby Yip

15 May, 2025

Jiangsu Hengrui Pharmaceuticals

Printed by Unregistered user on Fri, 05 Dec 2025 15:59:37 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's CATL looks to raise $4.6b in upsized Hong Kong IPO

China's Duality Biotherapeutics launches $200m Hong Kong IPO

Read more from Greater China

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report

Baidu’s Kunlunxin eyes Hong Kong IPO after $283m fundraising